Patent details

Herbas

VPB

Print

EN | LT

LT - CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER

EN - CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 38/10
		A61K 31/282
		A61K 31/337
		A61P 35/00

European patent
(11)	Number of the document	2841084
(13)	Kind of document	T
(96)	European patent application number	13727657.2
	Date of filing the European patent application	2013-04-24
(97)	Date of publication of the European application	2015-03-04
(45)	Date of publication and mention of the grant of the patent	2018-05-30
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/IL2013/050352
	Date	2013-04-24

PCT application publication
(87)	Number	WO 2013/160895
	Date	2013-10-31

Priority applications
(30)	Number	Date	Country code
	201261637334 P	2012-04-24	US

Inventors
(72)	PELED, Amnon, IL WALD, Ori, IL

Grantee
(73)	Biokine Therapeutics Ltd., Building 13a Einstein Street, Science Park Kiryat Weizmann, 70400 Nes Ziona, IL

Title
(54)	CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER
	CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER